Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
SHEZF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $0 | $156,590 | $0 | $0 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $0 | $0 | $0 | $0 |
| Other Non-Cash | $504,776 | $387,442 | $0 | $0 |
| Operating Cash Flow | $504,776 | $544,032 | $0 | $0 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$39,949 | -$41,013 | -$62,495 | -$52,927 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$803,398 | -$664,015 | -$712,804 | -$602,246 |
| Inv. Sales/Matur. | $1,058,647 | $472,009 | $637,909 | $382,488 |
| Other Inv. Act. | -$186,886 | -$24,533 | -$51,437 | -$113,600 |
| Investing Cash Flow | $28,414 | -$257,552 | -$188,826 | -$386,285 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$488,538 | $55,836 | -$743,728 | -$274,399 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | -$22,025 | -$24,391 | -$26,661 | -$39,406 |
| Other Fin. Act. | -$16,362 | -$8,843 | -$23,387 | -$3,326 |
| Financing Cash Flow | -$526,925 | $22,603 | -$793,775 | -$317,131 |
| Forex Effect | -$2,031 | $9,556 | $6,956 | -$1,120 |
| Net Chg. in Cash | $4,234 | $318,638 | -$573,652 | -$207,238 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,740,465 | $1,421,827 | $1,995,479 | $2,202,718 |
| End Cash | $1,744,699 | $1,740,465 | $1,421,827 | $1,995,479 |
| Free Cash Flow | $464,827 | $503,019 | $339,498 | $444,370 |